Trinity Biotech shares rise as FDA approves HIV test
Yahoo! FinanceShares of Trinity Biotech PLC (Nasdaq:TRIB) climbed Monday after the Irish company announced it had won approval to market its rapid HIV test in the U.S. Meanwhile, shares of a key U.S. competitor in the rapid HIV test market, OraSure Technologies Inc. (Nasdaq:OSUR), slid. The US Food and Drug Administration approved Trinity Biotech's 10-minute, one- step Uni-Gold Recombigen test to detect HIV antibodies in human serum, plasma or whole blood the first device to be approved for use with all three sample types, the company said.
—Posted: December 29, 2003
More news headlines: This week | Last week | Search archive